Walgreens January Sales Increase 6.3 Percent

  Walgreens January Sales Increase 6.3 Percent

Business Wire

DEERFIELD, Ill. -- February 5, 2013

Walgreens (NYSE: WAG) (Nasdaq: WAG) had January sales of $6.15 billion, an
increase of 6.3 percent from $5.78 billion for the same month in fiscal 2012.

Total front-end sales increased 1.3 percent compared with the same month in
fiscal 2012, while comparable store front-end sales decreased 0.4 percent.
Customer traffic in comparable stores decreased 2.8 percent while basket size
increased 2.4 percent.

Prescriptions filled at comparable stores increased by 13.6 percent in January
and increased 11.6 percent on a day-fall adjusted (DFA) basis. This year’s
January had one additional Wednesday and Thursday and one fewer Sunday and
Monday compared with January 2012, positively impacting prescriptions filled
in comparable stores by 2.0 percentage points. DFA prescriptions filled at
comparable stores were positively impacted by 2.3 percentage points due to the
higher incidence of flu in this year’s January and by 2.0 percentage points
due to more flu shots administered in the month.

The company said the percentage of Express Scripts customers filling
prescriptions in its pharmacies continued to increase in January.

January pharmacy sales increased by 8.7 percent, while comparable store
pharmacy sales increased 6.2 percent and by a day-fall adjusted 4.2 percent.
Calendar day shifts positively impacted pharmacy sales in comparable stores by
2.0 percentage points. DFA comparable store pharmacy sales were negatively
impacted by 6.0 percentage points due to generic drug introductions in the
last 12 months. Pharmacy sales accounted for 65 percent of total sales for the

Flu shots administered at pharmacies and clinics season-to-date were nearly
6.9 million versus approximately 5.5 million last year.

Sales in comparable stores increased by 3.7 percent in January. Calendar day
shifts positively impacted total comparable sales by 1.3 percentage points,
while generic drug introductions in the last 12 months negatively impacted
total comparable sales by 3.9 percentage points.

Registrations for Walgreens Balance^® Rewards loyalty program, which launched
in September, totaled nearly 55 million through January.

Fiscal 2013 year-to-date sales for the first five months were $30.18 billion,
down 2.4 percent from $30.93 billion in the comparable period in fiscal 2012.

Walgreens opened nine stores during January, including two relocations,
acquired two stores and closed two.

On Jan. 31, Walgreens operated 8,532 locations in all 50 states, the District
of Columbia, Puerto Rico and Guam. That includes 8,067 drugstores, 237 more
than a year ago, including 106 net stores acquired over the last 12 months.
The company also operates infusion and respiratory services facilities,
specialty pharmacies and mail service facilities. Its Take Care Health Systems
subsidiary manages more than 700 in-store convenient care clinics and worksite
health and wellness centers.

January Comparable Sales and Prescriptions Filled

                                                        Cough,     Flu
                                Calendar         Generics   Cold, Flu   Shot
                   Actual       Shift Impact     Impact     Impact      Impact
Total Comp         3.7   %      1.3      %       -3.9  %    0.9    %    0.7  %
Comp Front End     -0.4  %      -                -          -           -
Comp Rx Sales      6.2   %      2.0      %       -6.0  %    1.5    %    1.1  %
Comp Rx Scripts    13.6  %*     2.0      %       -          2.3    %    2.0  %

* Includes +0.9 percentage point from patients filling more 90-day

Please note: Sales numbers and the adjustments shown in the table are
preliminary, unaudited and subject to revision. Comparable stores are defined
as those drugstore locations open for at least 12 consecutive months without
closure for seven or more consecutive days and without a major remodel or a
natural disaster in the past 12 months. Acquired operating locations and
relocations are not included as comparable stores for the first 12 months
after the acquisition or relocation.

Cautionary Note Regarding Forward-Looking Statements: Statements in this
release that are not historical are forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. Words such as "expect," “likely,” "outlook," “forecast, "would,"
"could," "should," “can,” “will,” "project," "intend," "plan," "goal,”
“continue," "sustain," “synergy,” "on track," "believe," "seek," "estimate,"
"anticipate," "may," “possible,” "assume," and variations of such words and
similar expressions are intended to identify such forward-looking statements.
These forward-looking statements are not guarantees of future performance and
involve risks, assumptions and uncertainties, including, but not limited to,
those described in Item 1A (Risk Factors) of our most recent Annual Report on
Form 10-K, which is incorporated herein by reference, and in other documents
that we file or furnish with the Securities and Exchange Commission. Should
one or more of these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially from those
indicated or anticipated by such forward-looking statements. Accordingly, you
are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date they are made. Except to the extent required
by law, Walgreens does not undertake, and expressly disclaims, any duty or
obligation to update publicly any forward-looking statement after the date of
this report, whether as a result of new information, future events, changes in
assumptions or otherwise.


Media Contact:
Jim Graham, 847-315-2925
Investor Contacts:
Rick Hans, CFA, 847-315-2385
Ashish Kohli, 847-315-3810
Press spacebar to pause and continue. Press esc to stop.